Medsol India Overseas Private Limited

Medsol India Overseas Private Limited - pharma in Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U51101UP2010PTC039440 Incorporated 03 February 2010 ROC Kanpur HQ Noida, Uttar Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹34.67 Cr
▲ 17% YoY
Net profit · FY 2025
₹1.95 Cr
Net margin 5.6%
EBITDA · FY 2025
₹3.19 Cr
EBITDA margin 9.2%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹96.35 Lakh
Secured borrowings
Company age
16 yrs
Est. 2010
Employees · EPFO
194
Provident fund records

About Medsol India Overseas Private Limited

Data last updated:

Medsol India Overseas Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 February 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51101UP2010PTC039440. Its GSTIN is 09AAGCM3612H1ZK (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Kaushal Sahani and Vivek Upreti.

Its last annual general meeting (AGM) was held on 26 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 88 Sector – 63, Noida, Uttar Pradesh, India – 201301.

As per the financials filed for FY 2025, the company reported a revenue of ₹34.67 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹1.95 Cr (net margin 5.6%) and EBITDA of ₹3.19 Cr (EBITDA margin 9.2%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 11% over five years.

The company has about 194 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Medsol India Overseas. As per MCA filings, the company has open charges of ₹96.35 Lakh on record. Court records list 10 cases involving the company, including 1 filed by the company and 9 filed against it; 4 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medsolindia.com.

Company details

CIN U51101UP2010PTC039440
Registration Number 039440
Incorporation Date 03 February 2010
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Medsol India Overseas Private Limited's registered office is in Noida, Uttar Pradesh. Its website is medsolindia.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    B – 88 Sector – 63, Noida, Uttar Pradesh, India – 201301
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Medsol India Overseas Private Limited, buy the company report.

Comprehensive company report
Medsol India Overseas Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Medsol India Overseas operates one associated brand: Medsol India Overseas. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical products and services focused on medical solutions in India.medsolindia.in

Business activity

The main business activity of Medsol India Overseas is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Medsol India Overseas Private Limited, buy the company report.

Financials of Medsol India Overseas Private Limited

FY 2025 filings available

Medsol India Overseas Private Limited reported revenue of ₹34.67 Cr (up 17% YoY) for FY 2025.

Revenue · FY 2025
₹34.67 Cr ▲ 17%
Net profit · FY 2025
₹1.95 Cr margin 5.6%
EBITDA · FY 2025
₹3.19 Cr margin 9.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 20%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 30%
5 years · compounded
▲ 17%

Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 17% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.19 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.95 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.2%
Net Profit Margin5.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medsol India Overseas Private Limited, buy the company report.

Board of directors of Medsol India Overseas Private Limited

Medsol India Overseas has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kaushal SahaniDirector01 Jun 201313 Years 4 MonthsCurrent
Vivek UpretiDirector24 Apr 201511 Years 6 MonthsCurrent
Puneet SharmaDirector08 Oct 201412 Years 0 MonthsCurrent

Peer comparison

Medsol India Overseas Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Elixir Life Care Private Limited₹35.03 Cr (FY 2025)-1.0%Chennai, Tamil Nadu, India
Kumar Brothers Pharma Private Limited₹34.94 Cr (FY 2024)6.0%Mumbai, Maharashtra, India
Raghavam Logistics Private Limited₹34.67 Cr (FY 2025)-7.0%Raipur, Chhattisgarh, India
Medsol India Overseas Private Limitedthis company₹34.67 Cr (FY 2025)₹1.95 Cr5.6%17.0%194Noida, Uttar Pradesh, India
Aril Bioscience Private Limited₹34.52 Cr (FY 2025)36.0%Mumbai, Maharashtra, India
Adinarayan Associates Private Limited₹34.35 Cr (FY 2024)201.0%Cuttack, Odisha, India

To see the full peer comparison of Medsol India Overseas Private Limited, buy the company report.

Auditor

Medsol India Overseas Private Limited is audited by K.B. SHARMA & CO. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
K.B. SHARMA & CO.FY 2024002318N

Shareholding

The shareholding of Medsol India Overseas Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Medsol India Overseas Private Limited, buy the company report.

Charges & borrowings

Open charges
₹96.35 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹0.96 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
03 Oct 2023100829867Hdfc Bank Limited₹19.99 LakhOpen
30 Oct 2022100678996Hdfc Bank Limited₹64 LakhOpen
18 Apr 2022100578672Hdfc Bank Limited₹12.36 LakhOpen

Total charge records: 3 View all charges

MSME payment delays

Medsol India Overseas Private Limited has 3 MSME Form 1 returns on record between 2019 and 2021, listing 20 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 8)

SupplierAmount dueDue sinceReported on
Mascot Health Series Private Limited.
Elnova Pharma
Life Vision Health Care
Value Chain Solutions (India) Private Limited
Agrawal Drugs Private Limited

To see the full MSME payment records of Medsol India Overseas Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Medsol India Overseas Private Limited has a workforce of 194 employees on its EPFO records as of Feb 28, 2025, across 1 active EPFO establishment.

Employee count
194
Active EPFO establishments
1
Employee growth
22.01%

GST

Medsol India Overseas has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
09AAGCM3612H1ZKUttar PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Medsol India Overseas Private Limited, buy the company report.

Recent activity

Medsol India Overseas Private Limited has 7 board changes on record since 2013: 3 appointments and 4 cessations. The latest: Vivek Upreti ceased to be Additional Director on 29 Sep 2015.

AGM
Medsol India Overseas Private Limited last Annual general meeting of members was held on 26 Aug 2025 as per latest MCA records.
Filing
Medsol India Overseas Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 19.99 Lakh with Charge ID 100829867 was registered on 03 Oct 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 64.00 Lakh with Charge ID 100678996 was registered on 30 Oct 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 12.36 Lakh with Charge ID 100578672 was registered on 18 Apr 2022.
Ceased
Vivek Upreti ceased to be Additional Director.
Appointed
Vivek Upreti was appointed as Director.
Ceased
Davinder Singh Chawla ceased to be Director.
Appointed
Puneet Sharma was appointed as Director.
Ceased
Rita Upreti ceased to be Director.
Ceased
Sandhya Sharma ceased to be Director.
Appointed
Kaushal Sahani was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Medsol India Overseas is an active private limited company based in Noida, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 February 2010 (16+ years old) and is registered under CIN U51101UP2010PTC039440.

Medsol India Overseas has 3 current directors:

The latest financial statements of Medsol India Overseas on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 August 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Medsol India Overseas is 09AAGCM3612H1ZK, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Medsol India Overseas is U51101UP2010PTC039440. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medsol India Overseas has 10 court cases on record: 1 filed by the company and 9 filed against it. 4 are pending. Most are in the district courts.

Medsol India Overseas was incorporated on 03 February 2010, making it 16+ years old. It is registered with the Registrar of Companies, Kanpur.

The peers of Medsol India Overseas by revenue are Elixir Life Care Private Limited, Kumar Brothers Pharma Private Limited, Raghavam Logistics Private Limited, Aril Bioscience Private Limited, Adinarayan Associates Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Vivek Upreti ceased to be Additional Director on 29 Sep 2015. Vivek Upreti was appointed as Director on 24 Apr 2015. Davinder Singh Chawla ceased to be Director on 10 Feb 2015. Medsol India Overseas has 7 board changes on record in total.

Medsol India Overseas has 3 MSME Form 1 returns on record between 2019 and 2021, listing 20 overdue payments to 8 micro and small suppliers. The latest return was filed on 04 Aug 2021.

Medsol India Overseas can be reached through the website medsolindia.com. Its registered office is in Noida, Uttar Pradesh, India.

The registered office of Medsol India Overseas is at B – 88 Sector – 63, Noida, Uttar Pradesh, India – 201301.